221 related articles for article (PubMed ID: 20420878)
1. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite.
Wang F; Shi Y; Yadav S; Wang H
Toxicology; 2010 Jun; 273(1-3):12-8. PubMed ID: 20420878
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite.
Li Y; Shen L; Xu H; Pang Y; Xu Y; Ling M; Zhou J; Wang X; Liu Q
Toxicol Lett; 2011 Oct; 206(2):113-20. PubMed ID: 21726611
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
4. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
5. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
[TBL] [Abstract][Full Text] [Related]
6. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells.
Liao WT; Lin P; Cheng TS; Yu HS; Chang LW
Toxicol Appl Pharmacol; 2007 Dec; 225(2):162-70. PubMed ID: 17945324
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells.
Ouyang W; Li J; Ma Q; Huang C
Carcinogenesis; 2006 Apr; 27(4):864-73. PubMed ID: 16387740
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes.
Ouyang W; Ma Q; Li J; Zhang D; Liu ZG; Rustgi AK; Huang C
Cancer Res; 2005 Oct; 65(20):9287-93. PubMed ID: 16230390
[TBL] [Abstract][Full Text] [Related]
9. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
10. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
[TBL] [Abstract][Full Text] [Related]
11. The repressive effect of NF-kappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite.
Li Y; Ling M; Xu Y; Wang S; Li Z; Zhou J; Wang X; Liu Q
Toxicol Sci; 2010 Jul; 116(1):174-82. PubMed ID: 20375080
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.
Chilakapati J; Wallace K; Ren H; Fricke M; Bailey K; Ward W; Creed J; Kitchin K
Toxicology; 2010 Jan; 268(1-2):31-9. PubMed ID: 19945496
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B.
Han SW; Roman J
Oncogene; 2006 Jul; 25(31):4341-9. PubMed ID: 16518410
[TBL] [Abstract][Full Text] [Related]
15. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
[TBL] [Abstract][Full Text] [Related]
16. The role of oxidative stress in hormesis induced by sodium arsenite in human embryo lung fibroblast (HELF) cellular proliferation model.
Yang P; He XQ; Peng L; Li AP; Wang XR; Zhou JW; Liu QZ
J Toxicol Environ Health A; 2007 Jun; 70(11):976-83. PubMed ID: 17479414
[TBL] [Abstract][Full Text] [Related]
17. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro.
Shimizu M; Hochadel JF; Fulmer BA; Waalkes MP
Toxicol Sci; 1998 Oct; 45(2):204-11. PubMed ID: 9848127
[TBL] [Abstract][Full Text] [Related]
18. Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.
Ruan HY; Masuda M; Ito A; Umezawa K; Nakashima T; Yasumatsu R; Kuratomi Y; Yamamoto T; Weinstein IB; Komune S
Head Neck; 2006 Feb; 28(2):158-65. PubMed ID: 16355386
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter.
Park SG; Chung C; Kang H; Kim JY; Jung G
J Biol Chem; 2006 Oct; 281(42):31770-7. PubMed ID: 16940298
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of NF-kappaB and E2F by low concentration of arsenite in U937 human monocytic leukemia cells.
Yamamoto M; Hirano S; Vogel CF; Cui X; Matsumura F
J Biochem Mol Toxicol; 2008; 22(2):136-46. PubMed ID: 18418899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
